nach oben

Pathology & Oncology Research

Erschienen in:

31.08.2017 | Original Article

Oral Health May Affect the Performance of mRNA-Based Saliva Biomarkers for Oral Squamous Cell Cancer

verfasst von: József Horváth, Adrien Szabó, Ildikó Tar, Balázs Dezső, Csongor Kiss, Ildikó Márton, Beáta Scholtz

Erschienen in: Pathology & Oncology Research | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Oral squamous cell carcinoma (OSCC) has a dismal 50% five-year survival rate, emphasizing the need to develop reliable and sensitive tools for early diagnosis. In this study we evaluated the performance of 7 previously identified, potential mRNA biomarkers of OSCC in saliva samples of Hungarian patients. Expression of the putative OSCC biomarkers (DUSP1, OAZ1, H3F3A, IL1B, IL8, SAT and S100P), 2 biomarkers of inflammation (IL6 and TNFα) and 8 putative normalizing genes was quantified from each sample using real-time quantitative PCR. In contrast with previous studies, the expression pattern of the 7 mRNA biomarkers was similar between OSCC patients and age-matched control patients in the Hungarian patient population. On the other hand, 5 of the 7 mRNA biomarkers were present at significantly higher levels in saliva samples of OSCC patients when compared to young control patients. The best biomarker combination could distinguish only the OSCC vs. young control patients, but not the OSCC vs. age-matched control patients. In conclusion, the significant differences between our results and previous studies, and the clinical characteristics of the patients suggest that inflammatory processes in the oral cavity may affect the performance of the 7 putative salivary mRNA biomarkers. Lastly, since IL6 mRNA was quantifiable in the majority of OSCC cases, but only in a few control samples, salivary IL6 mRNA may be utilized as part of a biomarker combination to detect OSCC.

Nur mit Berechtigung zugänglich

Guerra EN, Acevedo AC, Leite AF, Gozal D, Chardin H, De Luca CG (2015) Diagnostic capability of salivary biomarkers in the assessment of head and neck cancer: a systematic review and meta-analysis. Oral Oncol 51(9):805–818. https://doi.org/10.1016/j.oraloncology.2015.06.010 CrossRefPubMed

Li Y, Zhou X, St John MA, Wong DT (2004) RNA profiling of cell-free saliva using microarray technology. J Dent Res 83(3):199–203. https://doi.org/10.1177/154405910408300303 CrossRefPubMed

Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC, Eisele D, Abemayor E, Elashoff D, Park NH, Wong DT (2004) Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 10(24):8442–8450. https://doi.org/10.1158/1078-0432.CCR-04-1167 CrossRefPubMed

Yakob M, Fuentes L, Wang MB, Abemayor E, Wong DT (2014) Salivary biomarkers for detection of oral squamous cell carcinoma - current state and recent advances. Curr Oral Health Rep 1(2):133–141. https://doi.org/10.1007/s40496-014-0014-y CrossRefPubMedPubMedCentral

Brinkmann O, Kastratovic DA, Dimitrijevic MV, Konstantinovic VS, Jelovac DB, Antic J, Nesic VS, Markovic SZ, Martinovic ZR, Akin D, Spielmann N, Zhou H, Wong DT (2011) Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population. Oral Oncol 47(1):51–55. https://doi.org/10.1016/j.oraloncology.2010.10.009 CrossRefPubMed

Elashoff D, Zhou H, Reiss J, Wang J, Xiao H, Henson B, Hu S, Arellano M, Sinha U, Le A, Messadi D, Wang M, Nabili V, Lingen M, Morris D, Randolph T, Feng Z, Akin D, Kastratovic DA, Chia D, Abemayor E, Wong DT (2012) Prevalidation of salivary biomarkers for oral cancer detection. Cancer Epidemiol Biomark Prev 21(4):664–672. https://doi.org/10.1158/1055-9965.EPI-11-1093 CrossRef

Lallemant B, Evrard A, Combescure C, Chapuis H, Chambon G, Raynal C, Reynaud C, Sabra O, Joubert D, Hollande F, Lallemant J-G, Lumbroso S, Brouillet J-P (2009) Clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinse. BMC Cancer 9:370. https://doi.org/10.1186/1471-2407-9-370 CrossRefPubMedPubMedCentral

Ervik M, Lam F, Ferlay J, Mery L, Soerjomataram I, Bray F (2016) Cancer today. Lyon, France: International Agency for Research on Cancer. Cancer today. Available from: http://gco.iarc.fr/today, accessed [01/05/2017]

Alevizos I, Mahadevappa M, Zhang X, Ohyama H, Kohno Y, Posner M, Gallagher GT, Varvares M, Cohen D, Kim D, Kent R, Donoff RB, Todd R, Yung CM, Warrington JA, Wong DT (2001) Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene 20(43):6196–6204. https://doi.org/10.1038/sj.onc.1204685 CrossRefPubMed

10.

Chen C, Méndez E, Houck J, Fan W, Lohavanichbutr P, Doody D, Yueh B, Futran ND, Upton M, Farwell DG, Schwartz SM, Zhao LP (2008) Gene expression profiling identifies genes predictive of oral squamous cell carcinoma. Cancer Epidemiol Biomark Prev 17(8):2152–2162. https://doi.org/10.1158/1055-9965.EPI-07-2893 CrossRef

11.

Sajnani MR, Patel AK, Bhatt VD, Tripathi AK, Ahir VB, Shankar V, Shah S, Shah TM, Koringa PG, Jakhesara SJ, Joshi CG (2012) Identification of novel transcripts deregulated in buccal cancer by RNA-seq. Gene 507(2):152–158CrossRefPubMed

12.

Jiang Q, Yu YC, Ding XJ, Luo Y, Ruan H (2014) Bioinformatics analysis reveals significant genes and pathways to target for oral squamous cell carcinoma. Asian Pac J Cancer Prev 15(5):2273–2278. https://doi.org/10.1016/j.gene.2012.07.036 CrossRefPubMed

13.

Liu J, Duan Y (2012) Saliva: A potential media for disease diagnostics and monitoring. Oral Oncol 48(7):569–577. https://doi.org/10.1016/j.oraloncology.2012.01.021 CrossRefPubMed

14.

Ottó S, Kásler M (2005) Trends in cancer mortality and morbidity in Hungarian and international statistics. Characteristics and potential outcome of public health screening programmes. Magy Onkol 49(2):99–101 103–7PubMed

15.

Suba Z, Mihályi S, Takács D, Gyulai-Gaál S (2009) Oral cancer: morbus Hungaricus in the 21st century. Fogorv Sz 102(2):63–68 PMID:19514245PubMed

16.

Hermann P, Gera I, Borbély J, Fejérdy P, Madléna M (2009) Periodontal health of an adult population in Hungary: findings of a national survey. J Clin Periodontol 36(6):449–457. https://doi.org/10.1111/j.1600-051X.2009.01395.x CrossRefPubMed

17.

Nemes JA, Nemes Z, Márton IJ (2005) p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma. J Oral Pathol Med 34(5):274–279. https://doi.org/10.1111/j.1600-0714.2005.00310.x CrossRefPubMed

18.

Nemes JA, Deli L, Nemes Z, Márton IJ (2006) Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102(3):344–352. https://doi.org/10.1016/j.tripleo.2005.10.069 CrossRefPubMed

19.

Lang NP, Corbet EF (1995) Periodontal diagnosis in daily practice. Int Dent J 45(1):3–15 PMID:7607742PubMed

20.

Beikler T, Flemmig TF (2011) Oral biofilm-associated diseases: trends and implications for quality of life, systemic health and expenditures. Periodontol 2000 55(1):87–103. https://doi.org/10.1111/j.1600-0757.2010.00360.x CrossRefPubMed

21.

Pindborg JJ, Reichart PA, Smith CJ, Van der Waal I (1997) Histological typing of cancer and precancer of the oral mucosa. WHO international histological classification of tumours, 2nd edn. Springer, BerlinCrossRef

22.

Head and neck tumors: Lip and oral cavity (2009) In: Sobin LH, Gospodarowitz MK, Wittekind CH, editors. TNM classification of malignant tumors. 7th ed. Wiley-Blackwell

23.

Mehdi Khanlou K, Van Bockstaele E (2012) A critique of widely used normalization software tools and an alternative method to identify reliable reference genes in red clover (Trifolium Pratense L.) Planta 236(5):1381–1393. https://doi.org/10.1007/s00425-012-1682-2 CrossRefPubMed

24.

Hu Z, Zimmermann BG, Zhou H, Wang J, Henson BS, Yu W, Elashoff D, Krupp G, Wong DT (2008) Exon-level expression profiling: a comprehensive transcriptome analysis of oral fluids. Clin Chem 54(5):824–832. https://doi.org/10.1373/clinchem.2007.096164 CrossRefPubMedPubMedCentral

25.

Cheng YS, Jordan L, Rees T, Chen HS, Oxford L, Brinkmann O, Wong D (2014) Levels of potential oral cancer salivary mRNA biomarkers in oral cancer patients in remission and oral lichen planus patients. Clin Oral Investig 18(3):985–993. https://doi.org/10.1007/s00784-013-1041-0 CrossRefPubMed

26.

Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3(7):RESEARCH0034 PMCID: PMC126239CrossRefPubMedPubMedCentral

27.

Andersen CL, Jensen JL, Ørntoft TF (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64(15):5245–5250. https://doi.org/10.1158/0008-5472.CAN-04-0496 CrossRefPubMed

28.

Cheng YL, Jordan L, Chen HS, Kang D, Oxford L, Plemons J, Parks H, Rees T (2017) Chronic periodontitis can affect the levels of potential oral cancer salivary mRNA biomarkers. J Periodontal Res 52(3):428–437. https://doi.org/10.1111/jre.12407 CrossRefPubMed

29.

Ganzetti G, Campanati A, Santarelli A, Sartini D, Molinelli E, Brisigotti V, Di Ruscio G, Bobyr I, Emanuelli M, Offidani A (2016) Salivary interleukin-1β: oral inflammatory biomarker in patients with psoriasis. J Int Med Res 44(1 suppl):10–14. https://doi.org/10.1177/0300060515598902 CrossRefPubMedPubMedCentral

30.

Nie S, Zhang H, Mayer KM, Oppenheim FG, Little FF, Greenberg J, Uluer AZ, Walt DR (2015) Correlations of salivary biomarkers with clinical assessments in patients with cystic fibrosis. PLoS One 10(8):e0135237. https://doi.org/10.1371/journal.pone.0135237 CrossRefPubMedPubMedCentral

31.

Rathnayake N, Akerman S, Klinge B, Lundegren N, Jansson H, Tryselius Y, Sorsa T, Gustafsson A (2013) Salivary biomarkers for detection of systemic diseases. PLoS One 8(4):e61356. https://doi.org/10.1371/journal.pone.0061356 CrossRefPubMedPubMedCentral

Titel: Oral Health May Affect the Performance of mRNA-Based Saliva Biomarkers for Oral Squamous Cell Cancer
verfasst von: József Horváth
Adrien Szabó
Ildikó Tar
Balázs Dezső
Csongor Kiss
Ildikó Márton
Beáta Scholtz
Publikationsdatum: 31.08.2017
Verlag: Springer Netherlands
Erschienen in: Pathology & Oncology Research / Ausgabe 4/2018
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI: https://doi.org/10.1007/s12253-017-0296-1

Springer Medizin

Oral Health May Affect the Performance of mRNA-Based Saliva Biomarkers for Oral Squamous Cell Cancer

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2018

MiR-184 Retarded the Proliferation, Invasiveness and Migration of Glioblastoma Cells by Repressing Stanniocalcin-2

Aspects of Modern Biobank Activity – Comprehensive Review

Is Lipidomic the Answer to the Search of a Biomarker for Organ Preservation Protocol in Head and Neck Squamous Cell Carcinoma?

Seminal Cell-Free DNA Assessment as a Novel Prostate Cancer Biomarker

ISUP Group 4 – a Homogenous Group of Prostate Cancers?

The B7 Family Member B7-H6: a New Bane of Tumor

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie